五洲医疗收盘上涨1.19%，滚动市盈率81.02倍，总市值28.94亿元

Core Viewpoint - Wuzhou Medical's stock closed at 42.56 yuan, marking a 1.19% increase, with a rolling PE ratio of 81.02, the lowest in 480 days, and a total market value of 2.894 billion yuan [1] Company Overview - Wuzhou Medical specializes in the research, manufacturing, and sales of disposable sterile infusion medical devices, as well as integrated supply of other diagnostic and nursing medical supplies [1] - The main products include syringes, safety syringes, insulin syringes, infusion sets, blood transfusion sets, injection needles, intravenous infusion needles, blood collection needles, insulin pen needles, safety needles, safety blood collection needles, blood pressure monitors, and masks [1] Financial Performance - For Q1 2025, Wuzhou Medical reported revenue of 104 million yuan, a year-on-year increase of 15.59%, while net profit was 5.6345 million yuan, reflecting a year-on-year decrease of 43.00%, with a gross profit margin of 14.62% [1] Shareholder Information - As of July 31, 2025, Wuzhou Medical had 7,255 shareholders, an increase of 848 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 56.56, with a median of 39.76, placing Wuzhou Medical at 101st in the industry ranking [1][2]